Topic Archives: Sanofi (SNY)

This will surely not be the last time Doc Gumshoe turns his attention to the pandemic that is now imposing misery on many parts of the world.   I need to acknowledge that when what was then generally called the Wuhan virus first came to my attention, I expressed the view that, despite the dire […]

Don’t look to Doc Gumshoe to keep you up to the minute on the spread of the Wuhan coronavirus.   The figures I’m quoting below are as of mid-day today, February 18th.   These will have changed by the time you see this piece, and they may be unreliable in the first place.   But, […]

When we’re trying to fight against an adversary that is as strong and full of tricks as cancer, what we need to do is look for points of vulnerability – Achilles heels.   We all remember, of course, that the mother of Achilles dipped him in the River Styx when he was a tiny boy, […]

[Ed note: Here is our latest piece from “Doc Gumshoe”, who is a medical writer (not a doctor) who shares his wisdom with us at Stock Gumshoe a couple times a month.  He does not typically write specifically about investments, but does write about publicly traded companies and their drugs, and has agreed to our trading […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “Thanks to you I’m much obliged Such a […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He choses his own topics, his words and opinions are his own, and he has agreed to our trading restrictions. You can see his Stock Gumshoe page here.] When I was an undergraduate student, I became a good friend of Michael D., […]

Everybody’s got to deviate from the norm.  —Rush John Galsworthy wrote that the beginning and endings of human undertakings are untidy. It was never more so than in the early days of HCV, a mere 20 years ago, when a plague first called “non-A non-B hepatitis” began vexing people, progressively scarring their livers and behaving […]

“I firmly believe that if the whole materia medica could be sunk to the bottom of the sea, it would be all the better for mankind and all the worse for the fishes.”  — Oliver Wendell Holmes, M. D., Professor of Medicine , Harvard “With all his conscience and one eye askew, So false he […]

[ed note: Michael Jorrin is a longtime medical writer (not a doctor) who covers health and medical topics and trends for our readers, generally without an investment thesis. His words are his own, enjoy!] In the Doc Gumshoe blog about cancer that appeared in June of 2013 (you can check it out here), I commented […]

[ed note: Dr. KSS is a paid contributor to Stock Gumshoe who writes about biotech stocks for (and discusses them with) the Irregulars. He chooses his own topics, and his words and opinions are his alone. Enjoy!] Greetings fellow Irregulars!  You’ve all been waiting for it….our first-ever annual ceremony in which we look back on […]

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Any discussion of cholesterol immediately turns Brobdingnagian, such are the extremes in question. Statins, which lower LDL cholesterol, are bombastically the best-selling drugs of all […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]

Comments

  • Avatar

    This must have come out literally right after I asked this question? Just found it. So glad I joined StockGumshoe! Goo...

  • Avatar

    I saw the same presentation regarding “5 Elite U.S. Stocks Set to Explode.” The e-mail made it sound like we would g...

  • Avatar

    A fairly new one that might do pretty well: $IVITF or $GENE in Canada. Also I am thinking $VPRB will do well though I wo...

  • SoGiAm

    10 risky nut rewarding stocks ro buy from #InvestorPlace https://investorplace.com/2018/01/risky-rewarding-small-cap-st...

  • Avatar

    Guess maybe I should have read the comments before subscribing to Slingshot Trader. As mentioned, this is just one of a...

  • Avatar

    I got one via InvestorPlace Special Offers. I listened to most of the spiel, but I don't have the funds to tap into the ...

  • SoGiAm

    PIRS-For more Form 4's filed 20K shares each: http://ir.pieris.com/all-sec-filings Tipranks.com : Analyst Name Firm ...

  • Avatar

    I see slingshot is not being advertised under investorplace which is a mass marketer. I feel that many sites that have...

  • Avatar

    Having read both the original court verdict and the appellate court decision upholding the guilty verdict against Stansb...

  • Avatar

    I joined...without searching internet. Looked at their track record...which they're stupid enough to post. Lost in 201...

  • Avatar

    I am glad I found this set of reviews for John Lansing ("JL" as he likes to be called) and his Trending123 Service. I ...

  • Avatar

    Without urgency, they can't convince you to subscribe! The Investorplace folks have a variety of ...

  • Avatar

    The way the service is marketing itself can tell you a lot about it. This service gives you a GUARANTEE of 50% gains per...

  • Avatar

    thanks dlst, my blog was shut down. I imagine the guys at investorplace got upset......

  • Avatar

    I have to agree with all the comments here, my time viewing the site was terrible, and yes I did suffer some losses, but...

  • Avatar

    I keep getting emails from John Lansing at options zone. At the bottom it tells us that it is sent from InvestorPlace. ...

  • Avatar

    Jamie and I had newsletters at the same time at InvestorPlace. He started with Al Frank of the Prudent Speculator, then...

  • Avatar

    And like Bryan Perry (25% Cash Machine...also Investorplace) she likes BDC's ...but is this superior to (AINV)?...

  • Avatar

    Good comment -- at one point one of the China investment newsletters (Cabot's, not Hsu's) was actually the best performi...

  • Avatar

    Been seeing this a bit more from Investorplace (Hsu and Navellier, at least), teaser stocks being touted in ads after th...

  • Avatar

    I agree that registering for the Portfolio Grader opens you up to a considerable e-mail from Louis but the hotlist secti...

  • Avatar

    I suppose you never know, but I'd be surprised. And of course, it's not Navellier himself doing this marketing, it's In...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info